Axcelis CFO Resigns, Interim Appointed Ahead of Annual Shareholder Meeting
Summary
Axcelis Technologies filed its definitive proxy statement, announcing the resignation of its CFO and the appointment of an interim replacement, while also detailing 2025 executive compensation and proposals for the upcoming annual meeting.
Key Events
-
CFO Resignation and Interim Appointment
James G. Coogan will resign as Executive Vice President and Chief Financial Officer, effective April 24, 2026, to pursue an opportunity in a different industry. David Ryzhik has been appointed Interim Chief Financial Officer, effective March 12, 2026.
-
Annual Meeting Scheduled
The Annual Meeting of Stockholders is scheduled for May 5, 2026, with proposals for the election of eight incumbent directors, ratification of Ernst & Young LLP as independent auditors, and an advisory vote on executive compensation.
-
2025 Executive Compensation Above Target
2025 executive compensation payouts were above target (CEO at 104%, other NEOs at 102%) due to strong performance against Adjusted EBITDA and operational goals, despite an 18% revenue decline in 2025.
-
Corporate Governance Practices Detailed
The filing details robust corporate governance practices, including insider trading policies, director and executive stock ownership guidelines, and a clawback policy for incentive compensation.
Analysis
This DEF 14A filing is significant due to the announced resignation of James G. Coogan, the Executive Vice President and Chief Financial Officer, effective April 24, 2026. His departure to pursue an opportunity in a different industry, coupled with the appointment of David Ryzhik as Interim CFO, introduces a degree of uncertainty regarding the company's financial leadership. The proxy statement also outlines proposals for the upcoming May 5, 2026 annual meeting, including the re-election of eight incumbent directors, the ratification of Ernst & Young LLP as independent auditors, and an advisory vote on 2025 executive compensation. Notably, 2025 executive compensation payouts were above target, which the company attributes to strong performance against Adjusted EBITDA and operational goals, despite a reported 18% revenue decline in 2025. Investors will likely monitor the search for a permanent CFO and the outcomes of the shareholder votes.
At the time of this filing, ACLS was trading at $90.43 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $40.40 to $102.93. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.